Close Asset Management LTD Adaptive Biotechnologies Corp Transaction History

Close Asset Management LTD

  • $3.55 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$6.4 - $14.73 $9,504 - $21,874
-1,485 Reduced 99.0%
15 $0
Q3 2021

Nov 04, 2021
SELL
$30.02 - $39.87 $93,062 - $123,596
-3,100 Reduced 67.39%
1,500 $51,000
Q2 2021

Jul 27, 2021
BUY
$32.22 - $44.59 $148,212 - $205,114
4,600 New
4,600 $188,000

Others Institutions Holding ADPT

# of Institutions
225
Shares Held
146M
Call Options Held
19.6K
Put Options Held
27.2K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.2B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email